1. Home/
  2. Compounds/
  3. SNX-2112:bortezomib (250:1 mol/mol)

SNX-2112:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2SNX-2112:bortezomib (250:1 mol/mol)
PharmacoGx SNX-2112:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to SNX-2112:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CHID1 CTRPv2 pan-cancer AAC -0.083 0.01
mRNA MAP3K7 CTRPv2 pan-cancer AAC 0.083 0.01
mRNA MRPL37 CTRPv2 pan-cancer AAC 0.082 0.01
mRNA AC069499.1 CTRPv2 pan-cancer AAC 0.086 0.01
mRNA HSH2D CTRPv2 pan-cancer AAC 0.093 0.01
mRNA NRDC CTRPv2 pan-cancer AAC 0.085 0.01
mRNA SOD3 CTRPv2 pan-cancer AAC -0.081 0.01
mRNA IMPDH2 CTRPv2 pan-cancer AAC 0.088 0.01
mRNA CHRNA5 CTRPv2 pan-cancer AAC 0.089 0.01
mRNA DIP2B CTRPv2 pan-cancer AAC -0.081 0.01
Download CSV